Longtime GC of Biotech That Discovered Leading Hep-C Cure Announces Retirement

Written by

News

in

Nathaniel Gardiner will retire at the end of March 2024, after 28 years with Entata Pharmaceuticals.

       
News
Author: News

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

More posts